Atsushi Yamashita

No ORCID on file · 4 papers in corpus · active 2015-2025

Study types

  • article 4

Condition tags

  • endometriosis 4
article 2025
Inhibition of VEGFR1 TK Signaling in Peritoneal Macrophages Suppresses Endometriosis Development
In vivo (Athens, Greece) ·doi:10.21873/invivo.14059

Background/Aim: Endometriosis is characterized by the accumulation of immune cells in endometrial lesions and the peritoneal cavity. Macrophages contribute to the growth and neovascularization of endometriotic lesions. Vascular endothelial …

article 2022
Thromboxane A2 receptor signaling inhibits angiogenesis and lymphangiogenesis in the endometriotic lesions in mice
·doi:10.1254/jpssuppl.96.0_2-b-p-091

Angiogenesis and lymphangiogenesis contribute to the development of endometriosis. We recently reported that thromboxane A2 (TXA2) receptor signaling involves in angiogenesis in critical limb ischemia and lymphangiogenesis in inflamed diaph…

article 2021
Tissue factor expression and tumor‐infiltrating T lymphocytes in ovarian carcinomas and their association with venous thromboembolism
Pathology international ·doi:10.1111/pin.13074

Ovarian cancer is a known risk factor of venous thromboembolism (VTE). Thrombogenic factor expression and lymphocytic infiltrate have been reported in endometriosis and ovarian cancers. We reviewed 30 cases of ovarian carcinomas (high grade…

article 2015
Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
Case reports in obstetrics and gynecology ·doi:10.1155/2015/690891

Ovarian seromucinous borderline tumors (SMBTs) are rare. They architecturally resemble serous borderline tumors but are much more frequently associated with endometriosis. The coexistence of other tumors with seromucinous tumors is also ext…